These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12531344)

  • 1. Costs and benefits of polio eradication: a long-run global perspective.
    Khan MM; Ehreth J
    Vaccine; 2003 Jan; 21(7-8):702-5. PubMed ID: 12531344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Updated Economic Analysis of the Global Polio Eradication Initiative.
    Thompson KM; Kalkowska DA
    Risk Anal; 2021 Feb; 41(2):393-406. PubMed ID: 33590521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risks, costs, and benefits of possible future global policies for managing polioviruses.
    Thompson KM; Tebbens RJ; Pallansch MA; Kew OM; Sutter RW; Aylward RB; Watkins M; Gary HE; Alexander J; Jafari H; Cochi SL
    Am J Public Health; 2008 Jul; 98(7):1322-30. PubMed ID: 18511720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective cost-effectiveness analyses for polio vaccination in the United States.
    Thompson KM; Tebbens RJ
    Risk Anal; 2006 Dec; 26(6):1423-40. PubMed ID: 17184390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic analysis of the global polio eradication initiative.
    Duintjer Tebbens RJ; Pallansch MA; Cochi SL; Wassilak SG; Linkins J; Sutter RW; Aylward RB; Thompson KM
    Vaccine; 2010 Dec; 29(2):334-43. PubMed ID: 21029809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eradication versus control for poliomyelitis: an economic analysis.
    Thompson KM; Tebbens RJD
    Lancet; 2007 Apr; 369(9570):1363-1371. PubMed ID: 17448822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterising the costs of the Global Polio Laboratory Network: a survey-based analysis.
    Duintjer Tebbens RJ; Diop OM; Pallansch MA; Oberste MS; Thompson KM
    BMJ Open; 2019 Jan; 9(1):e023290. PubMed ID: 30670511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of alternative polio immunization policies in South Africa.
    Griffiths UK; Botham L; Schoub BD
    Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization.
    Khan MM; Sharma S; Tripathi B; Alvarez FP
    Public Health; 2017 Jan; 142():31-38. PubMed ID: 28057194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost analysis of post-polio certification immunization policies.
    Sangrujee N; Cáceres VM; Cochi SL
    Bull World Health Organ; 2004 Jan; 82(1):9-15. PubMed ID: 15106295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The global eradication of poliomyelitis: progress and problems.
    Rey M; Girard MP
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):317-25. PubMed ID: 17923156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress towards global polio eradication.
    Hull HF
    Dev Biol (Basel); 2001; 105():3-7. PubMed ID: 11763334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protecting investments in polio eradication: the past, present and future of surveillance for acute flaccid paralysis.
    Heymann DL; De Gourville EM; Aylward RB
    Epidemiol Infect; 2004 Oct; 132(5):779-80. PubMed ID: 15473138
    [No Abstract]   [Full Text] [Related]  

  • 15. Infectious disease. Polio: no cheap way out.
    Roberts L
    Science; 2007 Apr; 316(5823):362-3. PubMed ID: 17446365
    [No Abstract]   [Full Text] [Related]  

  • 16. [Economic impact of introducing the injectable inactivated polio vaccine in Colombia].
    Alvis N; De la Hoz F; Narváez J
    Rev Panam Salud Publica; 2010 May; 27(5):352-9. PubMed ID: 20602069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress towards the global eradication of poliomyelitis.
    Hull HF; Ward NA
    World Health Stat Q; 1992; 45(2-3):280-4. PubMed ID: 1462662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polio eradication--target 2000.
    Gomber S; Agarwal KN
    Indian J Pediatr; 1996; 63(4):477-83. PubMed ID: 10832468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polio by the Numbers-A Global Perspective.
    Badizadegan K; Kalkowska DA; Thompson KM
    J Infect Dis; 2022 Oct; 226(8):1309-1318. PubMed ID: 35415741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.